Skip to content
value.today

Upperline Health, Inc.

🇺🇸 Nashville, Tennessee, USAHealth CareFounded 2016
Total raised
$44 M
2 rounds on record
Latest round
$14 M
Feb 2020
First round on record
Apr 2018
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Upperline Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2020$14 MNo. 2$10 to $50 million

Upperline Health, Inc.: Raise no. 2, Feb 2020

Investors in this round

6 investors had bought by the notice of Apr 22, 2021: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charlie Morgan · Executive Officer
  • David Thorpe · Executive Officer, Director
  • Darin Gordon · Director
  • Jeff Crisan · Director
  • Mike Lester · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Thorpe, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 22, 2021. Read the notice at the SEC.

equitySEC
Apr 2018$30 MNo. 1$10 to $50 million

Upperline Health, Inc.: Raise no. 1, Apr 2018

Investors in this round

7 investors had bought by the notice of Apr 18, 2018: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$30 M of $30 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Thorpe · Executive Officer, Director
  • Stephen Nash · Executive Officer
  • Jeff Crisan · Director
  • Mike Lester · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Thorpe, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 18, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Upperline Health, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2021).

    SEC Form D · Apr 2021

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2021

That is all the official record says: Upperline Health, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Upperline Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Upperline Health, Inc.
NameRoleNamed in
Charlie MorganExecutive officerApr 2021
David ThorpeExecutive officerApr 2021
Stephen NashExecutive officerApr 2018
Darin GordonDirectorApr 2021
David ThorpeDirectorApr 2021
Jeff CrisanDirectorApr 2021
Mike LesterDirectorApr 2021